icon-folder.gif   Conference Reports for NATAP  
 
  5th IAS Conference on HIV Pathogenesis, Treatment and Prevention
July 19th-22nd 2009
Capetown, South Africa
Back grey_arrow_rt.gif
 
 
 
Efficacy, safety and tolerability of dual therapy with raltegravir 400mg bid and atazanavir 200mg bid in antiretroviral experienced patients.
 
 
  Reported by Jules Levin
5th IAS Capetown July 19-22 2009
 
D. Ripamonti1,2, F. Maggiolo1,2, E. Bombana2, G. Gregis1,2, G. Quinzan1,2, A. Callegaro3and F. Suter1,2 Antiviral Research Unit1, Infectious Diseases Unit2, Microbiology and Virology Unit3at Ospedali Riuniti di Bergamo, Italy

image002.gif

image004.gif

image006.gif

RESULTS
 
Table 1: Baseline characteristics

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif